Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
Journal
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Journal Volume
57
Journal Issue
3
Pages
403 - 413
Date Issued
2024-03-08
Author(s)
Wu, Tzong-Yow
Tsai, Wan-Ting
Chen, Kai-Hsiang
Huang, Szu-Ting
Huang, Chun-Fu
Kuo, Po-Hsien
Abstract
Patients with hematological malignancies (HM) were at a high risk of developing severe disease from coronavirus disease 2019 (COVID-19). We aimed to assess the clinical outcome of COVID-19 in hospitalized patients with HM.
Subjects
Lymphoma; Respiratory failure; SARS-CoV-2; Stem cell transplant; Vaccination
SDGs
Type
journal article
